Christopher J. Whelan
Papers
1
Total Citations
22
H-Index
1
About
Christopher J. Whelan is a distinguished researcher in urologic oncology, with a primary focus on prostate cancer biomarker discovery and risk stratification. His major contributions center on improving the accuracy of active surveillance protocols for prostate cancer patients, particularly through the analysis of expressed prostatic secretion biomarkers. In his highly cited 2013 study, Whelan demonstrated that secretion-based biomarkers, including TMPRSS2:ERG models, significantly enhance the stratification of NCCN active surveillance candidates, offering a more precise method for identifying low-risk, organ-confined disease. This work, which has garnered 22 citations, addresses a critical clinical need: reducing unnecessary overtreatment while ensuring that aggressive cancers are not missed. Whelan’s research bridges molecular biology and clinical decision-making, providing urologists with tools to better predict disease progression. His achievements include advancing personalized medicine in prostate cancer management, where his models have been recognized for their potential to refine patient selection for active surveillance. For students and researchers, Whelan’s work exemplifies how translational biomarker research can directly impact clinical guidelines and patient outcomes.
Research Focus
Key Achievements
Top Papers
- 1